港股異動 | 友邦(1299.HK)大漲逾4% 貢獻恆指約100點升幅
格隆匯8月28日丨友邦(1299.HK)大漲逾4%,報80.7港元,總市值9757億港元。友邦暫貢獻恆指約100點升幅,而恆指升破25600點。摩根士丹利今日發表最新報告指,友邦保險股價於未來60上升的機會達60%至70%,主要由於其公佈在新任管理層下的業務發展策略,相信其估值在公佈上半年業績後已見底,現價已反映新型肺炎帶來的負面因素。該行給予友邦目標價87港元,評級“增持”。大和發表研究報告指,友邦保險(1299.HK)新任首席執行官李源祥在集團上半年業績簡報會上提到,友邦中國已全面展開其業務擴展,除了已在7個省份設立分部,集團亦確定了10至12個省份,作為擴展業務的潛在市場。該行維持友邦目標價100港元,以及買入評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.